Evidence map›Paper›PMID 38062541›Full record

ArticleThe Australian and New Zealand journal of psychiatry2024

Australian clinical feasibility considerations for treatment of PTSD with cannabinoid-augmented exposure therapy.

Luke J Ney, Wole Akosile, Christopher G Davey, Louise Pitcher, Kim Felmingham, Leah Mayo, Matthew Hill, Esben Strodl

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The Australian and New Zealand journal of psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Endocannabinoids inhibit contextual fear memory generalization via hippocampal GABAergic synaptic transmission.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luke J NeySchool of Psychology and Counselling, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.ORCID 0000-0003-0209-8366
Wole AkosileGreater Brisbane Clinical School, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-3183-9047
Christopher G DaveyDepartment of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0003-1431-3852
Louise PitcherTrauma Strong, Brisbane, QLD, Australia.
Kim FelminghamSchool of Psychological Sciences, Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia.
Leah MayoDepartment of Psychiatry and Hotchkiss Brain Institute, Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Matthew HillDepartment of Psychiatry and Hotchkiss Brain Institute, Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Esben StrodlSchool of Psychology and Counselling, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabinoidsImplosive TherapyStress Disorders, Post-TraumaticAustraliaFeasibility StudiesHumansTreatment OutcomeCannabinoids

Identifiers

PMID38062541
PMCPMC10903122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.